ID   PCS1N_RAT               Reviewed;         260 AA.
AC   Q9QXU9;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JAN-2024, entry version 100.
DE   RecName: Full=ProSAAS;
DE   AltName: Full=Proprotein convertase subtilisin/kexin type 1 inhibitor;
DE            Short=Proprotein convertase 1 inhibitor;
DE   AltName: Full=pro-SAAS;
DE   Contains:
DE     RecName: Full=KEP;
DE   Contains:
DE     RecName: Full=Big SAAS;
DE              Short=b-SAAS;
DE   Contains:
DE     RecName: Full=Little SAAS;
DE              Short=l-SAAS;
DE   Contains:
DE     RecName: Full=Big PEN-LEN;
DE              Short=b-PEN-LEN;
DE     AltName: Full=SAAS CT(1-49);
DE   Contains:
DE     RecName: Full=PEN;
DE   Contains:
DE     RecName: Full=PEN-20;
DE   Contains:
DE     RecName: Full=Little LEN;
DE              Short=l-LEN;
DE   Contains:
DE     RecName: Full=Big LEN;
DE              Short=b-LEN;
DE     AltName: Full=SAAS CT(25-40);
DE   Flags: Precursor;
GN   Name=Pcsk1n;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10632593; DOI=10.1523/jneurosci.20-02-00639.2000;
RA   Fricker L., McKinzie A.A., Sun J., Curran E., Qian Y., Yan L.,
RA   Patterson S.D., Courchesne P.L., Richards B., Levin N., Mzhavia N.,
RA   Devi L.A., Douglass J.;
RT   "Identification and characterization of proSAAS, a granin-like
RT   neuroendocrine peptide precursor that inhibits prohormone processing.";
RL   J. Neurosci. 20:639-648(2000).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=9630436; DOI=10.1159/000054314;
RA   Donadel G., Marinos N., DeSilva M.G., Lu J., Notkins A.L., Lan M.S.;
RT   "Molecular cloning and characterization of a highly basic protein, IA-4,
RT   expressed in pancreatic islets and brain.";
RL   Neuroendocrinology 67:190-196(1998).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH PCSK1.
RX   PubMed=10816562; DOI=10.1074/jbc.m001583200;
RA   Qian Y., Devi L.A., Mzhavia N., Munzer S., Seidah N.G., Fricker L.D.;
RT   "The C-terminal region of proSAAS is a potent inhibitor of prohormone
RT   convertase 1.";
RL   J. Biol. Chem. 275:23596-23601(2000).
RN   [4]
RP   PROTEOLYTIC PROCESSING (BIG SAAS; LITTLE SAAS; BIG PEN-LEN; PEN; PEN-20 AND
RP   BIG LEN).
RX   PubMed=11742530; DOI=10.1042/0264-6021:3610067;
RA   Mzhavia N., Qian Y., Feng Y., Che F.-Y., Devi L.A., Fricker L.D.;
RT   "Processing of proSAAS in neuroendocrine cell lines.";
RL   Biochem. J. 361:67-76(2002).
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=15935061; DOI=10.1111/j.1471-4159.2005.03138.x;
RA   Morgan D.J., Mzhavia N., Peng B., Pan H., Devi L.A., Pintar J.E.;
RT   "Embryonic gene expression and pro-protein processing of proSAAS during
RT   rodent development.";
RL   J. Neurochem. 93:1454-1462(2005).
CC   -!- FUNCTION: May function in the control of the neuroendocrine secretory
CC       pathway. Proposed be a specific endogenous inhibitor of PCSK1
CC       (PubMed:10632593, PubMed:10816562). ProSAAS and Big PEN-LEN, both
CC       containing the C-terminal inhibitory domain, but not the processed
CC       peptides reduce PCSK1 activity in the endoplasmic reticulum and Golgi.
CC       It reduces the activity of the 87 kDa form but not the
CC       autocatalytically derived 65 kDa form of PCSK1. Subsequent processing
CC       of proSAAS may eliminate the inhibition. Slows down convertase-mediated
CC       processing of proopiomelanocortin and proenkephalin. May control the
CC       intracellular timing of PCSK1 rather than its total level of activity
CC       (By similarity). {ECO:0000250|UniProtKB:Q9QXV0,
CC       ECO:0000269|PubMed:10632593, ECO:0000269|PubMed:10816562}.
CC   -!- FUNCTION: [Big LEN]: Endogenous ligand for GPR171. Neuropeptide
CC       involved in the regulation of feeding. {ECO:0000250|UniProtKB:Q9QXV0}.
CC   -!- FUNCTION: [PEN]: Endogenous ligand for GPR171. Neuropeptide involved in
CC       the regulation of feeding. {ECO:0000250|UniProtKB:Q9QXV0}.
CC   -!- SUBUNIT: Interacts via the C-terminal inhibitory domain with PCSK1 65
CC       kDa form. {ECO:0000269|PubMed:10816562}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q9QXV0}. Golgi
CC       apparatus, trans-Golgi network {ECO:0000250|UniProtKB:Q9QXV0}.
CC   -!- TISSUE SPECIFICITY: Expressed in adult brain (all major structural
CC       regions), adrenal gland (medulla) and spinal cord (dorsal and ventral
CC       horn). Expressed in pancreatic islands. {ECO:0000269|PubMed:10632593,
CC       ECO:0000269|PubMed:9630436}.
CC   -!- DEVELOPMENTAL STAGE: Expressed by 12.5 dpc in essentially all
CC       differentiating neurons in the mantle layer of the myelencephalon,
CC       metencephalon, diencephalon, spinal cord and several sympathetic
CC       ganglia. During later stages of prenatal development, widespread
CC       expression continues in post-mitotic neurons of both the CNS and PNS
CC       and begins in endocrine cells of the anterior and intermediate
CC       pituitary. {ECO:0000269|PubMed:15935061}.
CC   -!- DOMAIN: ProSAAS(1-180) increases secretion of enzymatically inactive
CC       PCSK1. {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal inhibitory domain is involved in inhibition of
CC       PCSK1. It corresponds to the probable processing intermediate Big PEN-
CC       LEN, binds to PCSK1 in vitro and contains the hexapeptide L-L-R-V-K-R,
CC       which, as a synthetic peptide, is sufficient for PCSK1 inhibition.
CC   -!- DOMAIN: [Big LEN]: The four C-terminal amino acids of Big LEN are
CC       sufficient to bind and activate GPR171. {ECO:0000250|UniProtKB:Q9QXV0}.
CC   -!- PTM: Proteolytically cleaved in the Golgi. Big SAAS, Little SAAS, PEN
CC       and Big LEN are the major processed peptides in proSAAS-overexpressing
CC       PC-12 phaeochromocytoma cells (lacking PCSK1 and PCSK2 endopeptidases).
CC       Peptides corresponding to PEN and a proSAAS aa 40-59 have been detected
CC       in wild-type PC-12 cells. {ECO:0000269|PubMed:11742530}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF181561; AAF22642.1; -; mRNA.
DR   RefSeq; NP_062152.1; NM_019279.1.
DR   AlphaFoldDB; Q9QXU9; -.
DR   SMR; Q9QXU9; -.
DR   BioGRID; 251598; 1.
DR   IntAct; Q9QXU9; 1.
DR   STRING; 10116.ENSRNOP00000009794; -.
DR   MEROPS; I49.001; -.
DR   iPTMnet; Q9QXU9; -.
DR   PhosphoSitePlus; Q9QXU9; -.
DR   jPOST; Q9QXU9; -.
DR   Ensembl; ENSRNOT00055046920; ENSRNOP00055038543; ENSRNOG00055027142.
DR   Ensembl; ENSRNOT00060043587; ENSRNOP00060036134; ENSRNOG00060025182.
DR   Ensembl; ENSRNOT00065018262; ENSRNOP00065013941; ENSRNOG00065011262.
DR   GeneID; 246333; -.
DR   KEGG; rno:246333; -.
DR   UCSC; RGD:3617; rat.
DR   AGR; RGD:3617; -.
DR   CTD; 27344; -.
DR   RGD; 3617; Pcsk1n.
DR   eggNOG; ENOG502RYS0; Eukaryota.
DR   InParanoid; Q9QXU9; -.
DR   OrthoDB; 5266977at2759; -.
DR   PhylomeDB; Q9QXU9; -.
DR   PRO; PR:Q9QXU9; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0030141; C:secretory granule; ISO:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; ISO:RGD.
DR   GO; GO:0004866; F:endopeptidase inhibitor activity; IDA:RGD.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; ISO:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016486; P:peptide hormone processing; ISO:RGD.
DR   GO; GO:0009409; P:response to cold; ISO:RGD.
DR   GO; GO:0002021; P:response to dietary excess; ISO:RGD.
DR   InterPro; IPR010832; ProSAAS.
DR   PANTHER; PTHR15531; PROSAAS; 1.
DR   PANTHER; PTHR15531:SF0; PROSAAS; 1.
DR   Pfam; PF07259; ProSAAS; 1.
PE   1: Evidence at protein level;
KW   Cleavage on pair of basic residues; Golgi apparatus; Neuropeptide;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..260
FT                   /note="ProSAAS"
FT                   /id="PRO_0000259691"
FT   PEPTIDE         34..59
FT                   /note="Big SAAS"
FT                   /id="PRO_0000259693"
FT   PEPTIDE         34..40
FT                   /note="KEP"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000259692"
FT   PEPTIDE         42..59
FT                   /note="Little SAAS"
FT                   /id="PRO_0000259694"
FT   PEPTIDE         221..260
FT                   /note="Big PEN-LEN"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000259695"
FT   PEPTIDE         221..242
FT                   /note="PEN"
FT                   /id="PRO_0000259696"
FT   PEPTIDE         221..240
FT                   /note="PEN-20"
FT                   /id="PRO_0000259697"
FT   PEPTIDE         245..260
FT                   /note="Big LEN"
FT                   /id="PRO_0000259698"
FT   PEPTIDE         245..254
FT                   /note="Little LEN"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000259699"
FT   REGION          34..215
FT                   /note="ProSAAS(1-180)"
FT   REGION          162..187
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          206..234
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          221..260
FT                   /note="C-terminal inhibitory domain; interacts with PCSK1"
FT   MOTIF           239..244
FT                   /note="Sufficient for inhibition of PCSK1"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   260 AA;  27414 MW;  C84F688BDEB5313E CRC64;
     MAGSPLLCGP RAGGVGLLVL LLLGLLRLPP TLSARPVKEP RSLSAASAPL AETSTPLRLR
     RAVPRGEAAG AVQELARALA HLLEAERQER ARAEAQEAED QQARVLAQLL RAWGSPRASD
     PPLAPDDDPD APAAQLARAL LRARLDPAAL AAQLVPAPAP AAALRPRPPV YDDGPTGPDV
     EDAADETPDV DPELLRYLLG RILTGSSEPE AAPAPRRLRR AVDQDLGPEV PPENVLGALL
     RVKRLENSSP QAPARRLLPP
//
